Pennant Investors’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,700
Closed -$361K 38
2024
Q2
$361K Hold
23,700
0.09% 26
2024
Q1
$447K Hold
23,700
0.11% 22
2023
Q4
$453K Buy
+23,700
New +$453K 0.1% 22